Cargando…

Comparison of Quality of Life Responses From Caregiver and Children Aged ≥7 Years Using the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment With Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule

Objective: Paediatric growth hormone deficiency (pGHD) affects 1/4,000 children. Treatment with daily sub-cutaneous injections of recombinant human growth hormone (r-hGH) increase height velocity and quality of life (QoL). A recent randomised controlled clinical trial (NCT02968004) evaluated the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loftus, Jane, Quitmann, Julia, Valluri, Srinivas, Pastrak, Aleksandra, Reiter, Lawrence, Roland, Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090654/ http://dx.doi.org/10.1210/jendso/bvab048.1374

Ejemplares similares

Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States
por: Bullinger, Monika, et al.
Publicado: (2015)

Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment
por: Bloemeke, Janika, et al.
Publicado: (2019)

Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument
por: Bullinger, Monika, et al.
Publicado: (2013)

FRI599 Quality Of Life In Girls With Turner Syndrome Using The Quality Of Life In Short Stature Youth Questionnaire (QoLISSY) - A Cross-sectional Study
por: Vijayakanthi, Nandini, et al.
Publicado: (2023)

Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
por: Horikawa, Reiko, et al.
Publicado: (2022)

OR21-04 Long-term Efficacy And Safety Of Once-weekly Somatrogon In Pediatric Subjects With Growth Hormone Deficiency: Results From Up To 8 Years Of Somatrogon Treatment
por: Zadik, Zvi, et al.
Publicado: (2023)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden
por: Bolin, Kristian, et al.
Publicado: (2013)

Associations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients’ and Parents’ Perspectives
por: Quitmann, Julia Hannah, et al.
Publicado: (2016)

Somatrogon for growth hormone deficiency
Publicado: (2022)

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
por: Deal, Cheri L, et al.
Publicado: (2022)

LifeStyle-Specific-Islands (LiSSI): Integrated Bioinformatics Platform for Genomic Island Analysis
por: Barbosa, Eudes, et al.
Publicado: (2017)

Acromegaly Quality of Life Questionnaire (AcroQoL)
por: Badia, Xavier, et al.
Publicado: (2004)

Health-Related Quality of Life, Stress, Caregiving Burden and Special Needs of Parents Caring for a Short-Statured Child—Review and Recommendations for Future Research
por: Lackner, Lea, et al.
Publicado: (2023)

RF26 | PSAT150 Growth Outcomes From the Phase 2 and Phase 3 Studies of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency: Comparisons With Published Literature and an International Growth Study Database
por: Cara, Jose, et al.
Publicado: (2022)

Explaining parent-child (dis)agreement in generic and short stature-specific health-related quality of life reports: do family and social relationships matter?
por: Quitmann, Julia, et al.
Publicado: (2016)

OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
por: Fisher, Dennis M, et al.
Publicado: (2020)

A new questionnaire for measuring quality of life - the Stark QoL
por: Hardt, Jochen
Publicado: (2015)

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
por: Cazzorla, Chiara, et al.
Publicado: (2014)

Quality of life as patient-reported outcomes: principles of assessment
por: Bullinger, Monika, et al.
Publicado: (2014)

Quality of Life in POP: Validity, Reliability and Responsiveness of the Prolapse Quality of Life Questionnaire (P-QoL) in Spanish Women
por: Sánchez-Sánchez, Beatriz, et al.
Publicado: (2020)

The Effect of Alterations in Consciousness on Quality of Life (QoL) in Epilepsy: Searching for Evidence
por: Charidimou, Andreas, et al.
Publicado: (2011)

Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change
por: Kulthanan, Kanokvalai, et al.
Publicado: (2019)

Neurology, Neurorehabilitation and Aspects Related to Neuro-Quality of Life (Neuro-QoL)
por: Purcarea, Victor Lorin
Publicado: (2019)

Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population
por: Danaei, Mina, et al.
Publicado: (2022)

Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
por: Hedayat, Kosar, et al.
Publicado: (2016)

The fertility quality of life (FertiQoL) tool: development and general psychometric properties(†)
por: Boivin, Jacky, et al.
Publicado: (2011)

Analysis of longitudinal oncology quality of life (QoL) data - are we getting it right?
por: Cocks, Kim, et al.
Publicado: (2013)

Development and validation of PozQoL: a scale to assess quality of life of PLHIV
por: Brown, Graham, et al.
Publicado: (2018)

Polish Validation of the SarQoL(®), a Quality of Life Questionnaire Specific to Sarcopenia
por: Konstantynowicz, Jerzy, et al.
Publicado: (2018)

The Fertility Quality of Life (FertiQoL) tool: development and general psychometric properties
por: Boivin, Jacky, et al.
Publicado: (2011)

Associations between the quality of life in sarcopenia measured with the SarQoL® and nutritional status
por: Kim, Yongtaek, et al.
Publicado: (2021)

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL(®) questionnaire
por: Geerinck, Anton, et al.
Publicado: (2021)

Quality of life (QoL) among COVID-19 recovered healthcare workers in Bangladesh
por: Rashid, Md Utba, et al.
Publicado: (2022)

Cross-cultural adaptation and validation of Sarcopenia and Quality of Life (SarQoL) in Brazil
por: Orlandi, Fabiana de Souza, et al.
Publicado: (2022)

Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®))
por: Kumar, Prabal, et al.
Publicado: (2023)

Does Quality of Care (QoC) Perception Influence the Quality of Life (QoL) in Women with Endometriosis? Results from an Italian Nationwide Survey during Covid Pandemic
por: Cofini, Vincenza, et al.
Publicado: (2022)

Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia
por: Jandhyala, Ravi
Publicado: (2022)

Quality of Life (QoL) Assessment in the Patients Operated with Either Laparoscopic or an Open Aortobifemoral Bypass for Aortoiliac Occlusive Disease (AIOD): 2 Years Results of a Randomized Controlled Trial
por: Sahba, Mehdi, et al.
Publicado: (2022)

Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study
por: Maniatis, Aristides K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbgfoe1go8ki6sq6jv17fsqnjg